Lv1
56 积分 2022-08-24 加入
The effect of growth hormone injections on the costochondral junction of the rat rib
1天前
待确认
Can EGFR be a therapeutic target in breast cancer?
16天前
已完结
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward
16天前
已完结
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
17天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
1个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
2个月前
已完结
The next generation of immunotherapies for lung cancers
2个月前
已完结
Phase II Trial of Gemcitabine/Carboplatin (plus Trastuzumab in HER2-Positive Disease) in Patients with Metastatic Breast Cancer
3个月前
已完结
皖公网安备34019202002308
